DocGo Announces Strong Third Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Needham & Company Reiterates Buy Rating on DocGo (DCGO) Following 'Beat and Raise'
November 8, 2022 7:02 AM ESTNeedham & Company analyst Ryan MacDonald reiterated a Buy rating and $14.00 price target on DocGo (NASDAQ: DCGO) following Q3 'beat and raise'.
The analyst commented, "We reiterate our Buy rating & $14 PT following DCGO's 3Q22 beat and raise. As of Sept, covid testing... More



